Cargando…
Risk of Heart Failure Hospitalization Associated With Cilostazol in Diabetes: A Nationwide Case–Crossover Study
Background and Objective: It has been suggested to avoid cilostazol, the first-line therapy for peripheral arterial disease, in patients with congestive heart failure (HF). The objective of this study was to evaluate the risk of hospitalization for heart failure (HHF) associated with cilostazol use...
Autores principales: | Wu, Cho-Kai, Lin, Jou-Wei, Wu, Li-Chiu, Chang, Chia-Hsuin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330376/ https://www.ncbi.nlm.nih.gov/pubmed/30666197 http://dx.doi.org/10.3389/fphar.2018.01467 |
Ejemplares similares
-
Risk of major adverse limb events in patients with type 2 diabetes mellitus receiving sodium glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists: A population-based retrospective cohort study
por: Lee, Yen-Chieh, et al.
Publicado: (2022) -
Cilostazol Ameliorates Peripheral Neuropathic Pain in Streptozotocin-Induced Type I Diabetic Rats
por: Cheng, Kuang-I., et al.
Publicado: (2022) -
Different angiotensin receptor blockers and incidence of diabetes: a nationwide population-based cohort study
por: Chang, Chia-Hsuin, et al.
Publicado: (2014) -
Pharmacological Potential of Cilostazol for Alzheimer’s Disease
por: Ono, Kenjiro, et al.
Publicado: (2019) -
Antihypertensive Agents and Risk of Parkinson's Disease: A Nationwide Cohort Study
por: Lee, Yen-Chieh, et al.
Publicado: (2014)